Multiple rodent studies have demonstrated that BPC 157 administration both locally and systemically reduces markers of gastric damage, accelerates mucosal healing in ulcer models, and appears to counteract the damage caused by NSAIDs and corticosteroids
A phase 2 clinical trial published in The New England Journal of Medicine enrolled 338 patients with a body-mass index of 30 or higher or those with a BMI of 27 to less than 30 with at least one weight-related condition
Even a single visible fiber or speck disqualifies the entire vial
This convenience factor is a massive reason why these newer-generation medications have become the standard of care
Qualification is based on multiple health factors including how much body fat and visceral fat you have, your health history, and how your weight is affecting your overall health not a single number on a scale
Your health is our priority, and were here to walk this journey with you every step of the way.